Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 10 March, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 500459 | NSE: PGHH

Procter & Gamble Hygiene and Health Care Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 7, 2025, 3:27 pm

Market Cap 43,662 Cr.
Current Price 13,451
High / Low 17,748/13,290
Stock P/E61.0
Book Value 291
Dividend Yield1.45 %
ROCE112 %
ROE78.9 %
Face Value 10.0
PEG Ratio32.19

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Procter & Gamble Hygiene and Health Care Ltd

Competitors of Procter & Gamble Hygiene and Health Care Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Honasa Consumer Ltd 7,271 Cr. 224 547/197107 35.50.00 %17.1 %% 10.0
Ambica Agarbathies Aroma & Industries Ltd 50.7 Cr. 29.8 37.0/23.219.1 60.60.00 %5.07 %3.65 % 10.0
Ador Multi Products Ltd 12.5 Cr. 26.7 45.9/23.4 23.20.00 %33.6 %26.7 % 10.0
Kaya Ltd 311 Cr. 237 702/218 1060.00 %80.4 %% 10.0
Jyothy Labs Ltd 12,111 Cr. 330 596/31032.5 51.41.06 %27.0 %21.2 % 1.00
Industry Average66,733.93 Cr1,892.7847.07109.300.81%36.43%29.37%4.94

All Competitor Stocks of Procter & Gamble Hygiene and Health Care Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 1,0939737761,0451,1378838531,1381,1331,0029321,1351,248
Expenses 797808709831847734638853824745813845877
Operating Profit 29616567214290149215285310257118290371
OPM % 27%17%9%20%26%17%25%25%27%26%13%26%30%
Other Income 7667914101616147810
Interest 37114432322-027
Depreciation 13131414141515141415131210
Profit before tax 28815158206282146207284309234112285364
Tax % 26%32%26%25%26%-13%27%26%26%34%28%26%26%
Net Profit 2121034315420716515121122915481212269
EPS in Rs 65.3331.6813.1147.5763.9150.8446.5964.9170.5247.5624.9765.2882.74

Last Updated: February 28, 2025, 8:47 pm

Below is a detailed analysis of the quarterly data for Procter & Gamble Hygiene and Health Care Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is ₹1,248.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,135.00 Cr. (Sep 2024) to ₹1,248.00 Cr., marking an increase of ₹113.00 Cr..
  • For Expenses, as of Dec 2024, the value is ₹877.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 845.00 Cr. (Sep 2024) to ₹877.00 Cr., marking an increase of ₹32.00 Cr..
  • For Operating Profit, as of Dec 2024, the value is ₹371.00 Cr.. The value appears strong and on an upward trend. It has increased from 290.00 Cr. (Sep 2024) to ₹371.00 Cr., marking an increase of ₹81.00 Cr..
  • For OPM %, as of Dec 2024, the value is 30.00%. The value appears strong and on an upward trend. It has increased from 26.00% (Sep 2024) to 30.00%, marking an increase of 4.00%.
  • For Other Income, as of Dec 2024, the value is ₹10.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Sep 2024) to ₹10.00 Cr., marking an increase of ₹2.00 Cr..
  • For Interest, as of Dec 2024, the value is ₹7.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Sep 2024) to ₹7.00 Cr., marking an increase of ₹5.00 Cr..
  • For Depreciation, as of Dec 2024, the value is ₹10.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12.00 Cr. (Sep 2024) to ₹10.00 Cr., marking a decrease of 2.00 Cr..
  • For Profit before tax, as of Dec 2024, the value is ₹364.00 Cr.. The value appears strong and on an upward trend. It has increased from 285.00 Cr. (Sep 2024) to ₹364.00 Cr., marking an increase of ₹79.00 Cr..
  • For Tax %, as of Dec 2024, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 26.00%.
  • For Net Profit, as of Dec 2024, the value is ₹269.00 Cr.. The value appears strong and on an upward trend. It has increased from 212.00 Cr. (Sep 2024) to ₹269.00 Cr., marking an increase of ₹57.00 Cr..
  • For EPS in Rs, as of Dec 2024, the value is 82.74. The value appears strong and on an upward trend. It has increased from ₹65.28 (Sep 2024) to 82.74, marking an increase of ₹17.46.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 9:28 pm

MetricJun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024TTM
Sales 1,6772,0512,3342,2752,3202,4552,9473,0023,5743,9013,9184,2064,317
Expenses 1,4201,6281,8381,6671,6461,8342,3292,3962,6883,0693,0483,2303,280
Operating Profit 2564234956086756226186068868328699761,037
OPM % 15%21%21%27%29%25%21%20%25%21%22%23%24%
Other Income 61786485671845423823404739
Interest 056610556611112731
Depreciation 31355352605250484853585650
Profit before tax 286460501636672582607594870790839939996
Tax % 29%34%31%34%36%36%31%27%25%27%19%28%
Net Profit 203302346422433375419433652576678675716
EPS in Rs 62.6093.04106.63130.16133.31115.40129.12133.42200.79177.37208.91207.95220.55
Dividend Payout % 40%30%28%28%292%35%68%79%157%90%89%123%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year
YoY Net Profit Growth (%)
Change in YoY Net Profit Growth (%)

No data available for trend analysis.

Growth

Compounded Sales Growth
10 Years:7%
5 Years:7%
3 Years:6%
TTM:8%
Compounded Profit Growth
10 Years:8%
5 Years:10%
3 Years:1%
TTM:-5%
Stock Price CAGR
10 Years:7%
5 Years:6%
3 Years:-4%
1 Year:-14%
Return on Equity
10 Years:53%
5 Years:69%
3 Years:80%
Last Year:79%

Last Updated: Unknown

Balance Sheet

Last Updated: February 12, 2025, 4:16 pm

MonthJun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Dec 2024
Equity Capital 32323232323232323232323232
Reserves 7739701,1961,6194947738771,125682705914742913
Borrowings 0000000035433
Other Liabilities 4445057195156346207086719159401,1871,0811,149
Total Liabilities 1,2491,5081,9482,1661,1601,4251,6171,8281,6331,6832,1371,8592,097
Fixed Assets 215240309317286250234206184164170139145
CWIP 41983935412115223844232833
Investments 0000000000000
Other Assets 9931,1701,6001,8148341,1541,3681,6001,4111,4751,9451,6921,919
Total Assets 1,2491,5081,9482,1661,1601,4251,6171,8281,6331,6832,1371,8592,097

Below is a detailed analysis of the balance sheet data for Procter & Gamble Hygiene and Health Care Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Dec 2024, the value is ₹32.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2024) which recorded ₹32.00 Cr..
  • For Reserves, as of Dec 2024, the value is ₹913.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹742.00 Cr. (Jun 2024) to ₹913.00 Cr., marking an increase of 171.00 Cr..
  • For Borrowings, as of Dec 2024, the value is ₹3.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Jun 2024) which recorded ₹3.00 Cr..
  • For Other Liabilities, as of Dec 2024, the value is ₹1,149.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹1,081.00 Cr. (Jun 2024) to ₹1,149.00 Cr., marking an increase of 68.00 Cr..
  • For Total Liabilities, as of Dec 2024, the value is ₹2,097.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹1,859.00 Cr. (Jun 2024) to ₹2,097.00 Cr., marking an increase of 238.00 Cr..
  • For Fixed Assets, as of Dec 2024, the value is ₹145.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹139.00 Cr. (Jun 2024) to ₹145.00 Cr., marking an increase of 6.00 Cr..
  • For CWIP, as of Dec 2024, the value is ₹33.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹28.00 Cr. (Jun 2024) to ₹33.00 Cr., marking an increase of 5.00 Cr..
  • For Investments, as of Dec 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2024) which recorded ₹0.00 Cr..
  • For Other Assets, as of Dec 2024, the value is ₹1,919.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,692.00 Cr. (Jun 2024) to ₹1,919.00 Cr., marking an increase of 227.00 Cr..
  • For Total Assets, as of Dec 2024, the value is ₹2,097.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,859.00 Cr. (Jun 2024) to ₹2,097.00 Cr., marking an increase of 238.00 Cr..

Notably, the Reserves (₹913.00 Cr.) exceed the Borrowings (3.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthJun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024
Cash from Operating Activity +104335426352445415413474863573826471
Cash from Investing Activity +-31-13528221149-1934757-27-101
Cash from Financing Activity +-85-95-105-122-1,559-106-314-190-1,106-569-477-862
Net Cash Flow-12105349452-964290134358-236-23339-390

Free Cash Flow

MonthJun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024
Free Cash Flow256.00423.00495.00608.00675.00622.00618.00606.00883.00827.00865.00973.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthJun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024
Debtor Days181518242122222015182021
Inventory Days625347537148606878554851
Days Payable106103148134145156162175237183213193
Cash Conversion Cycle-27-35-83-57-53-87-79-87-144-110-145-121
Working Capital Days514348-15-23-12-21-38-34-53-32
ROCE %39%52%46%45%64%89%73%58%94%110%101%112%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Promoters70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%
FIIs2.57%2.63%2.25%2.03%1.68%1.12%1.05%1.13%1.30%1.48%1.57%1.56%
DIIs13.48%13.48%13.89%14.19%14.56%15.28%15.44%15.49%15.45%15.29%15.11%15.16%
Public13.31%13.26%13.22%13.14%13.12%12.96%12.87%12.73%12.61%12.60%12.67%12.65%
No. of Shareholders41,12040,90840,81941,53343,44540,49539,96839,38837,06938,80739,99940,671

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
SBI Focused Equity Fund1,000,0004.741661.3430,0002025-03-07132.56%
SBI Equity Hybrid Fund430,0001714.36430,0002025-03-070%
ICICI Prudential Bluechip Fund333,2820.93553.68430,0002025-03-07-22.49%
SBI Magnum Global Fund210,0005.22348.87430,0002025-03-07-51.16%
SBI Magnum Midcap Fund200,0001.64332.26430,0002025-03-07-53.49%
Aditya Birla Sun Life MNC Fund - Div72,4852.99120.42430,0002025-03-07-83.14%
Aditya Birla Sun Life MNC Fund - Gr72,4852.99120.42430,0002025-03-07-83.14%
ICICI Prudential Large & Mid Cap Fund62,4110.72103.68430,0002025-03-07-85.49%
UTI MNC Fund38,0102.0463.15430,0002025-03-07-91.16%
SBI Consumption Opportunities Fund38,0002.6363.13430,0002025-03-07-91.16%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthJun 24Jun 23Jun 22Jun 21Jun 20
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 207.95208.91177.37200.79133.42
Diluted EPS (Rs.) 207.95208.91177.37200.79133.42
Cash EPS (Rs.) 225.36226.89193.66215.48148.17
Book Value[Excl.RevalReserv]/Share (Rs.) 238.71291.44227.22220.05356.70
Book Value[Incl.RevalReserv]/Share (Rs.) 238.71291.44227.22220.05356.70
Dividend / Share (Rs.) 255.00185.00160.00315.00105.00
Revenue From Operations / Share (Rs.) 1295.661206.991201.761101.09924.83
PBDIT / Share (Rs.) 315.00280.10263.16284.55199.57
PBIT / Share (Rs.) 297.59262.12246.87269.87184.82
PBT / Share (Rs.) 289.34258.62243.42267.99182.95
Net Profit / Share (Rs.) 207.95208.91177.37200.80133.42
PBDIT Margin (%) 24.3123.2021.8925.8421.57
PBIT Margin (%) 22.9621.7120.5424.5019.98
PBT Margin (%) 22.3321.4220.2524.3319.78
Net Profit Margin (%) 16.0517.3014.7518.2314.42
Return on Networth / Equity (%) 87.1171.6878.0691.2537.40
Return on Capital Employeed (%) 110.0380.8597.31109.8748.64
Return On Assets (%) 36.3131.7234.2439.9223.68
Asset Turnover Ratio (%) 2.112.052.352.071.74
Current Ratio (X) 1.221.381.321.342.23
Quick Ratio (X) 0.991.181.051.041.89
Inventory Turnover Ratio (X) 3.473.745.224.975.22
Dividend Payout Ratio (NP) (%) 127.4369.4098.66169.3235.97
Dividend Payout Ratio (CP) (%) 117.5963.9090.36157.7932.39
Earning Retention Ratio (%) -27.4330.601.34-69.3264.03
Cash Earning Retention Ratio (%) -17.5936.109.64-57.7967.61
Interest Coverage Ratio (X) 38.1879.9076.34151.17106.72
Interest Coverage Ratio (Post Tax) (X) 26.2160.5952.45107.6872.35
Enterprise Value (Cr.) 53361.7845454.0942869.0042606.6732060.95
EV / Net Operating Revenue (X) 12.6911.6010.9911.9210.68
EV / EBITDA (X) 52.1949.9950.1946.1349.49
MarketCap / Net Operating Revenue (X) 12.8311.8511.1512.1110.98
Retention Ratios (%) -27.4330.591.33-69.3264.02
Price / BV (X) 69.6349.0858.9960.5828.47
Price / Net Operating Revenue (X) 12.8311.8511.1512.1110.98
EarningsYield 0.010.010.010.010.01

After reviewing the key financial ratios for Procter & Gamble Hygiene and Health Care Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Jun 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Jun 23) which recorded 10.00.
  • For Basic EPS (Rs.), as of Jun 24, the value is 207.95. This value is within the healthy range. It has decreased from 208.91 (Jun 23) to 207.95, marking a decrease of 0.96.
  • For Diluted EPS (Rs.), as of Jun 24, the value is 207.95. This value is within the healthy range. It has decreased from 208.91 (Jun 23) to 207.95, marking a decrease of 0.96.
  • For Cash EPS (Rs.), as of Jun 24, the value is 225.36. This value is within the healthy range. It has decreased from 226.89 (Jun 23) to 225.36, marking a decrease of 1.53.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Jun 24, the value is 238.71. It has decreased from 291.44 (Jun 23) to 238.71, marking a decrease of 52.73.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Jun 24, the value is 238.71. It has decreased from 291.44 (Jun 23) to 238.71, marking a decrease of 52.73.
  • For Dividend / Share (Rs.), as of Jun 24, the value is 255.00. This value exceeds the healthy maximum of 3. It has increased from 185.00 (Jun 23) to 255.00, marking an increase of 70.00.
  • For Revenue From Operations / Share (Rs.), as of Jun 24, the value is 1,295.66. It has increased from 1,206.99 (Jun 23) to 1,295.66, marking an increase of 88.67.
  • For PBDIT / Share (Rs.), as of Jun 24, the value is 315.00. This value is within the healthy range. It has increased from 280.10 (Jun 23) to 315.00, marking an increase of 34.90.
  • For PBIT / Share (Rs.), as of Jun 24, the value is 297.59. This value is within the healthy range. It has increased from 262.12 (Jun 23) to 297.59, marking an increase of 35.47.
  • For PBT / Share (Rs.), as of Jun 24, the value is 289.34. This value is within the healthy range. It has increased from 258.62 (Jun 23) to 289.34, marking an increase of 30.72.
  • For Net Profit / Share (Rs.), as of Jun 24, the value is 207.95. This value is within the healthy range. It has decreased from 208.91 (Jun 23) to 207.95, marking a decrease of 0.96.
  • For PBDIT Margin (%), as of Jun 24, the value is 24.31. This value is within the healthy range. It has increased from 23.20 (Jun 23) to 24.31, marking an increase of 1.11.
  • For PBIT Margin (%), as of Jun 24, the value is 22.96. This value exceeds the healthy maximum of 20. It has increased from 21.71 (Jun 23) to 22.96, marking an increase of 1.25.
  • For PBT Margin (%), as of Jun 24, the value is 22.33. This value is within the healthy range. It has increased from 21.42 (Jun 23) to 22.33, marking an increase of 0.91.
  • For Net Profit Margin (%), as of Jun 24, the value is 16.05. This value exceeds the healthy maximum of 10. It has decreased from 17.30 (Jun 23) to 16.05, marking a decrease of 1.25.
  • For Return on Networth / Equity (%), as of Jun 24, the value is 87.11. This value is within the healthy range. It has increased from 71.68 (Jun 23) to 87.11, marking an increase of 15.43.
  • For Return on Capital Employeed (%), as of Jun 24, the value is 110.03. This value is within the healthy range. It has increased from 80.85 (Jun 23) to 110.03, marking an increase of 29.18.
  • For Return On Assets (%), as of Jun 24, the value is 36.31. This value is within the healthy range. It has increased from 31.72 (Jun 23) to 36.31, marking an increase of 4.59.
  • For Asset Turnover Ratio (%), as of Jun 24, the value is 2.11. It has increased from 2.05 (Jun 23) to 2.11, marking an increase of 0.06.
  • For Current Ratio (X), as of Jun 24, the value is 1.22. This value is below the healthy minimum of 1.5. It has decreased from 1.38 (Jun 23) to 1.22, marking a decrease of 0.16.
  • For Quick Ratio (X), as of Jun 24, the value is 0.99. This value is below the healthy minimum of 1. It has decreased from 1.18 (Jun 23) to 0.99, marking a decrease of 0.19.
  • For Inventory Turnover Ratio (X), as of Jun 24, the value is 3.47. This value is below the healthy minimum of 4. It has decreased from 3.74 (Jun 23) to 3.47, marking a decrease of 0.27.
  • For Dividend Payout Ratio (NP) (%), as of Jun 24, the value is 127.43. This value exceeds the healthy maximum of 50. It has increased from 69.40 (Jun 23) to 127.43, marking an increase of 58.03.
  • For Dividend Payout Ratio (CP) (%), as of Jun 24, the value is 117.59. This value exceeds the healthy maximum of 50. It has increased from 63.90 (Jun 23) to 117.59, marking an increase of 53.69.
  • For Earning Retention Ratio (%), as of Jun 24, the value is -27.43. This value is below the healthy minimum of 40. It has decreased from 30.60 (Jun 23) to -27.43, marking a decrease of 58.03.
  • For Cash Earning Retention Ratio (%), as of Jun 24, the value is -17.59. This value is below the healthy minimum of 40. It has decreased from 36.10 (Jun 23) to -17.59, marking a decrease of 53.69.
  • For Interest Coverage Ratio (X), as of Jun 24, the value is 38.18. This value is within the healthy range. It has decreased from 79.90 (Jun 23) to 38.18, marking a decrease of 41.72.
  • For Interest Coverage Ratio (Post Tax) (X), as of Jun 24, the value is 26.21. This value is within the healthy range. It has decreased from 60.59 (Jun 23) to 26.21, marking a decrease of 34.38.
  • For Enterprise Value (Cr.), as of Jun 24, the value is 53,361.78. It has increased from 45,454.09 (Jun 23) to 53,361.78, marking an increase of 7,907.69.
  • For EV / Net Operating Revenue (X), as of Jun 24, the value is 12.69. This value exceeds the healthy maximum of 3. It has increased from 11.60 (Jun 23) to 12.69, marking an increase of 1.09.
  • For EV / EBITDA (X), as of Jun 24, the value is 52.19. This value exceeds the healthy maximum of 15. It has increased from 49.99 (Jun 23) to 52.19, marking an increase of 2.20.
  • For MarketCap / Net Operating Revenue (X), as of Jun 24, the value is 12.83. This value exceeds the healthy maximum of 3. It has increased from 11.85 (Jun 23) to 12.83, marking an increase of 0.98.
  • For Retention Ratios (%), as of Jun 24, the value is -27.43. This value is below the healthy minimum of 30. It has decreased from 30.59 (Jun 23) to -27.43, marking a decrease of 58.02.
  • For Price / BV (X), as of Jun 24, the value is 69.63. This value exceeds the healthy maximum of 3. It has increased from 49.08 (Jun 23) to 69.63, marking an increase of 20.55.
  • For Price / Net Operating Revenue (X), as of Jun 24, the value is 12.83. This value exceeds the healthy maximum of 3. It has increased from 11.85 (Jun 23) to 12.83, marking an increase of 0.98.
  • For EarningsYield, as of Jun 24, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Jun 23) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Procter & Gamble Hygiene and Health Care Ltd as of March 10, 2025 is: ₹11,366.90

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 10, 2025, Procter & Gamble Hygiene and Health Care Ltd is Overvalued by 15.49% compared to the current share price 13,451.00

Intrinsic Value of Procter & Gamble Hygiene and Health Care Ltd as of March 10, 2025 is: 11,582.31

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 10, 2025, Procter & Gamble Hygiene and Health Care Ltd is Overvalued by 13.89% compared to the current share price 13,451.00

Last 5 Year EPS CAGR: 1.90%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 73.58%, which is a positive sign.
  2. The stock has a low average Working Capital Days of -10.17, which is a positive sign.
  3. The stock has a low average Cash Conversion Cycle of -85.67, which is a positive sign.
  4. The company has higher reserves (906.38 cr) compared to borrowings (1.38 cr), indicating strong financial stability.
  5. The company has shown consistent growth in sales (2.54 cr) and profit (674.77 cr) over the years.

    Stock Analysis

    • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Procter & Gamble Hygiene and Health Care Ltd:
      1. Net Profit Margin: 16.05%
        • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
      2. ROCE: 110.03% (Industry Average ROCE: 36.43%)
        • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
      3. ROE%: 87.11% (Industry Average ROE: 29.37%)
        • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
      4. Interest Coverage Ratio (Post Tax): 26.21
        • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
      5. Quick Ratio: 0.99
        • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
      6. Stock P/E: 61 (Industry average Stock P/E: 47.07)
        • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
      7. Total Debt / Equity: 0
        • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
      The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
      Stock Rating:

    About the Company - Qualitative Analysis

    Procter & Gamble Hygiene & Healthcare Ltd. is a Public Limited Listed company incorporated on 20/07/1964 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1964PLC012971 and registration number is 012971. Currently Company is involved in the business activities of Manufacture of wadding of textile materials and articles of wadding such as sanitary napkins and tampoons. Company's Total Operating Revenue is Rs. 4205.70 Cr. and Equity Capital is Rs. 32.46 Cr. for the Year ended 30/06/2024.
    INDUSTRYADDRESSCONTACT
    Personal CareP & G Plaza, Cardinal Gracias Road, Mumbai Maharashtra 400099investorpghh.im@pg.com
    http://www.pg.com
    Management
    NamePosition Held
    Mr. Chittranjan DuaChairman & Ind.Director
    Mr. Kumar VenkatasubramanianManaging Director
    Mr. Ghanashyam HegdeExecutive Director
    Mr. Pramod AgarwalNon Executive Director
    Ms. Sonali DhawanNon Executive Director
    Mr. Gagan SawhneyNon Executive Director
    Mr. Krishnamurthy IyerIndependent Director
    Mr. Gurcharan DasIndependent Director
    Dr. Ashima GoyalIndependent Director

    FAQ

    What is the latest intrinsic value of Procter & Gamble Hygiene and Health Care Ltd?

    The latest intrinsic value of Procter & Gamble Hygiene and Health Care Ltd as on 10 March 2025 is ₹11366.90, which is 15.49% lower than the current market price of 13,451.00, indicating the stock is overvalued by 15.49%. The intrinsic value of Procter & Gamble Hygiene and Health Care Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹43,662 Cr. and recorded a high/low of ₹17,748/13,290 during the current fiscal year 2024-2025. As of Dec 2024, the company has reserves of ₹913 Cr and total liabilities of ₹2,097 Cr.

    What is the Market Cap of Procter & Gamble Hygiene and Health Care Ltd?

    The Market Cap of Procter & Gamble Hygiene and Health Care Ltd is 43,662 Cr..

    What is the current Stock Price of Procter & Gamble Hygiene and Health Care Ltd as on 10 March 2025?

    The current stock price of Procter & Gamble Hygiene and Health Care Ltd as on 10 March 2025 is ₹13,451.

    What is the High / Low of Procter & Gamble Hygiene and Health Care Ltd stocks in FY 2024-2025?

    In FY 2024-2025, the High / Low of Procter & Gamble Hygiene and Health Care Ltd stocks is ₹17,748/13,290.

    What is the Stock P/E of Procter & Gamble Hygiene and Health Care Ltd?

    The Stock P/E of Procter & Gamble Hygiene and Health Care Ltd is 61.0.

    What is the Book Value of Procter & Gamble Hygiene and Health Care Ltd?

    The Book Value of Procter & Gamble Hygiene and Health Care Ltd is 291.

    What is the Dividend Yield of Procter & Gamble Hygiene and Health Care Ltd?

    The Dividend Yield of Procter & Gamble Hygiene and Health Care Ltd is 1.45 %.

    What is the ROCE of Procter & Gamble Hygiene and Health Care Ltd?

    The ROCE of Procter & Gamble Hygiene and Health Care Ltd is 112 %.

    What is the ROE of Procter & Gamble Hygiene and Health Care Ltd?

    The ROE of Procter & Gamble Hygiene and Health Care Ltd is 78.9 %.

    What is the Face Value of Procter & Gamble Hygiene and Health Care Ltd?

    The Face Value of Procter & Gamble Hygiene and Health Care Ltd is 10.0.

    Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Procter & Gamble Hygiene and Health Care Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE